US Stock MarketDetailed Quotes

GSK GlaxoSmithKline

Watchlist

39.060
-0.070-0.18%

Trading Oct 15 10:06 ET

80.95BMarket Cap15.32P/E (TTM)

GlaxoSmithKline Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GlaxoSmithKline Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 7.930B	--
--	2024/Q3	-- / 8.164B	--
Jul 31, 2024	2024/Q2	7.884B / 7.493B	--
May 1, 2024	2024/Q1	7.363B / 7.060B	--
--	2023/Q4	8.052B / 7.621B	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 7.930B--

--2024/Q3-- / 8.164B--

Jul 31, 20242024/Q27.884B / 7.493B--

May 1, 20242024/Q17.363B / 7.060B--

--2023/Q48.052B / 7.621B--

Unlock Free Earnings Estimates

Open Account

GlaxoSmithKline Earnings Reports

6-K: Gsk Delivers Continued Strong Performance and Upgrades 2024 Guidance

Jul 31 12:31 ET

6-K: Gsk Makes a Strong Start to 2024 with Improving Outlook for the Year

May 1 12:34 ET

GlaxoSmithKline | 6-K: Glaxosmithkline 2023 Annual Report on Form 20-F

Mar 5 13:13 ET

GlaxoSmithKline | 20-F: FY2023 Annual Report

Mar 5 12:18 ET

Analyst Rating

Updated: Oct 2, 2024

Buy

Buy
75.00%
Hold
0.00%
Sell
25.00%

Price Target

No Data

Heat List

Overall

No Data